한국, 일본, 대만에서의 의약품 부작용 피해구제 제도 현황 조사

• 영문명: Current Status of Adverse Drug Reaction Relief System in Korea, Japan and Taiwan
• 발행기관: 대한약학회
• 저자명: 안상완(Sang-Wan An) 노윤하(Yunha Noh) 백연희(Yeon-Hee Baek) 박한희(Han-Heui Park) 박소희(So-Hee Park) 박성민(Sungmin Park) 신주영(Ju-Young Shin)
• 간행물 정보: 『약학회지』제63권 제4호(2019년), 214~220쪽, 전체 7쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2019.08.30

영문 초록

Abstract The adverse drug reaction relief system is no-fault compensation system which provides compensation for severe injuries that were caused by adverse reaction even after proper use of medicines. The purpose of this study is to evaluate current status of the adverse drug reaction relief system in Japan, Taiwan, and Korea. We investigated the relief system in above three countries through websites, literatures, reports, spot investigation and e-mail questionnaires. Although great similarities for the relief system were recognized among the three countries, the difference among the countries and the unique characteristics of each country’s relief system was also identified; for example, the relief for injuries by offlabel uses, details of relief benefits, the relief payment for the adverse drug reactions, and the compensation for medical expenses which is classified as non-reimbursement treatment. Therefore, it is possible to establish more valuable no-fault compensation system in Korea through application of advantage and experience for the relief system in Japan and Taiwan.

목차

서 론(Introduction)

연구방법(Research Methods)

결 과(Results)

고 찰(Discussion)

결 론(Conclusion)

키워드

adverse drug reaction relief system no-fault compensation drug injury non-reimbursement treatment off-label use